Skip to content

Effect of use of Lactobacillus plantarum UBLP-40 in addition iron supplement on anemia in pregnant women

Effect of supplementation of Lactobacillus plantarum UBLP-40 in addition to oral iron on iron status in nonanemic pregnant women with iron deficiency â?? a double blind placebo-controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073839
Enrollment
240
Registered
2024-09-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O990- Anemia complicating pregnancy, childbirth and the puerperium

Interventions

Intervention1: Probiotic UBLP-40: intervention group will receive Lactobacillus plantarum UBLP-40 (10 billion CFU (1x 1010 CFU (powdered in stick packs) and 1 stick per day, one hour before a meal) fo

Sponsors

Unique Biotech
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy pregnant women aged 18-35 years of age 2. Single live fetus of 12-16 weeks of gestation (USG confirmation) 3. Hemoglobin more than or equal to 11 gm% within 15 days before the enrollment 4. Iron deficiency as demonstrated by serum ferritin levels less than 15 ng per ml or less than 30 ng per ml in case of inflammation (CRP more than or equal to 5 mg per dl) 5. Willing to stay in the study area during the study duration

Exclusion criteria

Exclusion criteria: 1. Women with significant medical co-morbidities 2. Women with bad obstetric history 3. Women who have consumed probiotic supplements within 15 days before study participation 4. Not willing to sign written informed consent

Design outcomes

Primary

MeasureTime frame
1.Mean change in ferritin levels as compared to baseline 2.Mean change in total hemoglobin as compared to baseline Timepoint: at the end of 12 weeks on intervention

Secondary

MeasureTime frame
Mean change in hemoglobin levelsTimepoint: 35 weeks of gestation;Mean change in ferritin levelsTimepoint: 35 weeks of gestation;Mean change in reticulocyte hemoglobin levelsTimepoint: at the end of intervention and 35 weeks of pregnancy.;4. Proportion of participants with iron deficiency, anemia and iron deficiency anemiaTimepoint: at the end of the intervention and 35 weeks of gestation;Mean change in RBC and reticulocyte indicesTimepoint: at the end of the intervention and 35 weeks of gestation;Change in gut microbiome will be estimated using 16sRNA analysis in the subgroupTimepoint: at the end of the intervention

Countries

India

Contacts

Public ContactAditi Apte

KEM Hospital Research Centre Pune

aditi.apte@kemhrcvadu.org9975950227

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026